Dow Up0.75% Nasdaq Down0.25%

Osiris Therapeutics, Inc. (OSIR)

13.88 Up 0.18(1.31%) 11:09AM EDT - Nasdaq Real Time Price
ProfileGet Profile for:
Osiris Therapeutics, Inc.
7015 Albert Einstein Drive
Columbia, MD 21046
United States - Map
Phone: 443-545-1800
Fax: 443-545-1701

Index Membership:N/A
Full Time Employees:70

Business Summary 

Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing products to treat medical conditions in wound care, orthopedic, and sports medicine markets. The company’s stem cell drug, remestemcel-L, is indicated for graft versus host disease. Its products include Grafix and Ovation for acute and chronic wounds; Cartiform, a viable cartilage mesh for cartilage repair; and OvationOS, a viable bone matrix. It markets and distributes its products directly to hospitals and clinics, as well as through a network of distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Osiris Therapeutics, Inc.

Corporate Governance 
Osiris Therapeutics, Inc.’s ISS Governance QuickScore as of Oct 1, 2014 is 6. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 6; Compensation: 6.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Peter Friedli , 60
Co-Founder and Chairman
Dr. Lode Debrabandere Ph.D., MBA, 50
Chief Exec. Officer, Pres and Director
Mr. Philip R. Jacoby Jr., 61
Chief Financial Officer, Treasurer and Corp. Sec.
Dr. Douglas Jacobstein M.D.,
Sr. Medical Director
Mr. Frank D. Czworka Jr., 45
VP and Gen. Mang. of Wound Care
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders